Literature DB >> 29053396

Embryonic stem cell secreted factors decrease invasiveness of triple-negative breast cancer cells through regulome modulation.

Elizabeth Tarasewicz1, Robert S Oakes2, Misael O Aviles3, Joelle Straehla1, Kathryn M Chilton1, Joseph T Decker2, Jia Wu3, Lonnie D Shea2,3, Jacqueline S Jeruss2,4.   

Abstract

Stem cell microenvironments decrease the invasiveness of cancer cells, and elucidating the mechanisms associated with disease regression could further the development of targeted therapies for aggressive cancer subtypes. To this end, we applied an emerging technology, TRanscriptional Activity CEll aRray (TRACER), to investigate the reprogramming of triple-negative breast cancer (TNBC) cells in conditions that promoted a less aggressive phenotype. The repressive environment was established through exposure to mouse embryonic stem cell conditioned media (mESC CM). Assessment of carcinogenic phenotypes indicated that mESC CM exposure decreased proliferation, invasion, migration, and stemness in TNBC cells. Protein expression analysis revealed that mESC CM exposure increased expression of the epithelial protein E-cadherin and decreased the mesenchymal protein MMP9. Gene expression analysis showed that mESC CM decreased epithelial to mesenchymal transition (EMT) markers fibronectin, vimentin, and Snail. Over a period of 6 d, TRACER quantified changes in activity of 11 transcription factors (TFs) associated with oncogenic progression. The EMT profile was decreased in association with the activity of 7 TFs (Smad3, NF-κΒ, MEF2, GATA, Hif1, Sp1, and RXR). Further examination of Smad3 and GATA expression and phosphorylation revealed that mESC CM exposure decreased noncanonical Smad3 phosphorylation and Smad3-mediated gene expression, increased GATA3 expression and phosphorylation, and resulted in a synergistic decrease in migration of GATA3 overexpressing MDA-MB-231 cells. Collectively, the application of TRACER to examine TF activity associated with the transition of cancer cells to a less aggressive phenotype, as directed by mESC CM, identified novel mechanistic events linking the embryonic microenvironment to both favorable changes and cellular plasticity in TNBC cell phenotypes.

Entities:  

Keywords:  breast cancer; cancer stem cell; embryonic stem cell; epithelial-mesenchymal transition; metastasis; microenvironment; transcription factors

Mesh:

Substances:

Year:  2018        PMID: 29053396      PMCID: PMC5902235          DOI: 10.1080/15384047.2017.1385681

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  61 in total

1.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 2.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

3.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

Review 4.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

5.  Dynamics and control of state-dependent networks for probing genomic organization.

Authors:  Indika Rajapakse; Mark Groudine; Mehran Mesbahi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

6.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

Review 7.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

8.  GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.

Authors:  Wei Yan; Qing Jackie Cao; Richard B Arenas; Brooke Bentley; Rong Shao
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

9.  Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo.

Authors:  Rie Ayuzawa; Chiyo Doi; Raja Shekar Rachakatla; Marla M Pyle; Dharmendra Kumar Maurya; Deryl Troyer; Masaaki Tamura
Journal:  Cancer Lett       Date:  2009-03-13       Impact factor: 8.679

10.  Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation.

Authors:  Carmen Chak-Lui Wong; Daniele M Gilkes; Huafeng Zhang; Jasper Chen; Hong Wei; Pallavi Chaturvedi; Stephanie I Fraley; Chun-Ming Wong; Ui-Soon Khoo; Irene Oi-Lin Ng; Denis Wirtz; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

View more
  4 in total

1.  Biomaterial Scaffolds Recruit an Aggressive Population of Metastatic Tumor Cells In Vivo.

Authors:  Grace G Bushnell; Tejaswini P Hardas; Rachel M Hartfield; Yining Zhang; Robert S Oakes; Scott Ronquist; Haiming Chen; Indika Rajapakse; Max S Wicha; Jacqueline S Jeruss; Lonnie D Shea
Journal:  Cancer Res       Date:  2019-02-26       Impact factor: 12.701

2.  Cellular contractile forces are nonmechanosensitive.

Authors:  Lea Feld; Lior Kellerman; Abhishek Mukherjee; Ariel Livne; Eran Bouchbinder; Haguy Wolfenson
Journal:  Sci Adv       Date:  2020-04-22       Impact factor: 14.136

3.  The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2.

Authors:  Nicoletta Bianchi; Federica Brugnoli; Silvia Grassilli; Karine Bourgeois; Jeffrey W Keillor; Carlo M Bergamini; Gianluca Aguiari; Stefano Volinia; Valeria Bertagnolo
Journal:  Cells       Date:  2021-11-06       Impact factor: 6.600

4.  Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer.

Authors:  Gianluca Aguiari; Francesca Crudele; Cristian Taccioli; Linda Minotti; Fabio Corrà; Jeffrey W Keillor; Silvia Grassilli; Carlo Cervellati; Stefano Volinia; Carlo M Bergamini; Nicoletta Bianchi
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.